Literature DB >> 15715678

Blood coagulation and its regulation by anticoagulant pathways: genetic pathogenesis of bleeding and thrombotic diseases.

Björn Dahlbäck1.   

Abstract

Blood coagulation and its regulation by anticoagulant pathways: genetic pathogenesis Platelet-mediated primary haemostasis and blood coagulation have evolved as important defence mechanisms against bleeding. The formation of the platelet plug provides the initial occlusion of the vascular lesion. This is temporally co-ordinated with the activation of the coagulation system, which occurs in response to the rupture of endothelium and the exposure of blood to the extravascular tissue. The reactions of blood coagulation are carefully controlled by several anticoagulant mechanisms and under normal conditions they prevail over the procoagulant forces. Genetic or acquired disturbances of the natural balance between the pro- and anticoagulant systems may result in bleeding or thrombotic diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15715678     DOI: 10.1111/j.1365-2796.2004.01444.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  28 in total

1.  Deposition of fibrinogen on the surface of in vitro thrombi prevents platelet adhesion.

Authors:  Hadil Owaynat; Ivan S Yermolenko; Ramya Turaga; Valeryi K Lishko; Michael R Sheller; Tatiana P Ugarova
Journal:  Thromb Res       Date:  2015-10-09       Impact factor: 3.944

2.  The cost-benefit ratio of screening pregnant women for thrombophilia.

Authors:  Gian Luca Salvagno; Giuseppe Lippi; Massimo Franchini; Giovanni Targher; Martina Montagnana; Massimo Franchi; Gian Cesare Guidi
Journal:  Blood Transfus       Date:  2007-11       Impact factor: 3.443

Review 3.  The impact of inherited thrombophilia on surgery: a factor to consider before transplantation?

Authors:  Elias Kfoury; Ali Taher; Said Saghieh; Zaher K Otrock; Rami Mahfouz
Journal:  Mol Biol Rep       Date:  2008-05-31       Impact factor: 2.316

4.  Reevaluation of the role of HDL in the anticoagulant activated protein C system in humans.

Authors:  Cecilia Oslakovic; Eva Norstrøm; Björn Dahlbäck
Journal:  J Clin Invest       Date:  2010-05       Impact factor: 14.808

5.  Does the oxidation of methionine in thrombomodulin contribute to the hypercoaguable state of smokers and diabetics?

Authors:  Wesley E Stites; Jeffrey W Froude
Journal:  Med Hypotheses       Date:  2006-10-24       Impact factor: 1.538

6.  A Mathematical Model of Venous Thrombosis Initiation.

Authors:  Priscilla Elizondo; Aaron L Fogelson
Journal:  Biophys J       Date:  2016-12-20       Impact factor: 4.033

7.  Losac, the first hemolin that exhibits procogulant activity through selective factor X proteolytic activation.

Authors:  Miryam Paola Alvarez-Flores; Daniel Furlin; Oscar H P Ramos; Andrea Balan; Katsuhiro Konno; Ana Marisa Chudzinski-Tavassi
Journal:  J Biol Chem       Date:  2010-12-22       Impact factor: 5.157

8.  Quebec platelet disorder is linked to the urokinase plasminogen activator gene (PLAU) and increases expression of the linked allele in megakaryocytes.

Authors:  Maria Diamandis; Andrew D Paterson; Johanna M Rommens; D Kika Veljkovic; Jessica Blavignac; Dennis E Bulman; John S Waye; Francine Derome; Georges E Rivard; Catherine P M Hayward
Journal:  Blood       Date:  2008-11-06       Impact factor: 22.113

Review 9.  The use of PEGylated liposomes in the development of drug delivery applications for the treatment of hemophilia.

Authors:  Rivka Yatuv; Micah Robinson; Inbal Dayan-Tarshish; Moshe Baru
Journal:  Int J Nanomedicine       Date:  2010-09-07

Review 10.  Do neutrophil extracellular traps contribute to the heightened risk of thrombosis in inflammatory diseases?

Authors:  Ashish N Rao; Nayef M Kazzaz; Jason S Knight
Journal:  World J Cardiol       Date:  2015-12-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.